«The movement to the clinical
phase of the research is the result of tireless colleagues reaching across
disciplines in pursuit of the shared goal of hoping to someday improve the lives of individuals with Alzheimer's disease and possibly other brain disorders,
such as schizophrenia,» Provost and Vice Chancellor for Academic Affairs Susan R. Wente, Ph.D. said.